| 0.00% |
| 4 | Invesco Ltd. | 836K | $100.3M | +105.6% | 1.817% | 0.01% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 799K | $95.9M | +338.1% | 1.738% | 0.00% |
| 6 | Neuberger Berman Group LLC | 764K | $91.7M | +7.8% | 1.662% | 0.03% |
| 7 | BAMCO INC /NY/ | 742K | $89.0M | +0.1% | 1.613% | 0.13% |
| 8 | WASATCH ADVISORS LP | 518K | $62.2M | +40.2% | 1.126% | 0.41% |
| 9 | MILLENNIUM MANAGEMENT LLC | 425K | $51.0M | — | 0.924% | 0.02% |
| 10 | FULLER & THALER ASSET MANAGEMENT, INC. | 419K | $50.2M | — | 0.910% | 0.14% |
| 11 | EMERALD ADVISERS, LLC | 376K | $45.1M | +56.9% | 0.817% | 1.06% |
| 12 | NEXT CENTURY GROWTH INVESTORS LLC | 364K | $43.7M | +302.4% | 0.792% | 2.32% |
| 13 | UBS Group AG | 344K | $41.3M | +183.1% | 0.749% | 0.01% |
| 14 | JPMORGAN CHASE & CO | 340K | $41.0M | +20.2% | 0.740% | 0.00% |
| 15 | AMERIPRISE FINANCIAL INC | 321K | $38.5M | +45.7% | 0.697% | 0.01% |
| 16 | OBERWEIS ASSET MANAGEMENT INC/ | 299K | $35.9M | — | 0.650% | 0.74% |
| 17 | WELLS FARGO & COMPANY/MN | 272K | $32.6M | +24408.5% | 0.590% | 0.01% |
| 18 | Napean Trading & Investment Co (Singapore) PTE Ltd | 233K | $28.0M | 0.0% | 0.507% | 9.62% |
| 19 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 224K | $26.9M | -6.9% | 0.487% | 0.00% |
| 20 | EMERALD MUTUAL FUND ADVISERS TRUST | 204K | $24.5M | +54.3% | 0.443% | 0.86% |
| 21 | ALLIANCEBERNSTEIN L.P. | 262K | $20.7M | +17.4% | 0.570% | 0.01% |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 146K | $17.5M | +185.6% | 0.318% | 0.00% |
| 23 | Penn Capital Management Company, LLC | 130K | $15.5M | +2.6% | 0.282% | 0.99% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 123K | $14.7M | +1531487.5% | 0.266% | 0.01% |
| 25 | GOLDMAN SACHS GROUP INC | 120K | $14.4M | +2793.8% | 0.262% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in BLLN — a direct measure of their conviction.
| 0.12% |
| +0.00 pp |
| $0M |
| +0.0% |
| Q4 2024 | 1 | +0.0% | 0.12% | +0.00 pp | $0M | +0.0% |
| Q3 2024 | 1 | — | 0.12% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
74 institutions opened new positions in BLLN during Q2 2026, while 11 fully exited. 74 added to existing positions and 5 trimmed.
BLLN institutional ownership rose by 8.75 percentage points quarter-over-quarter, with a net change of +66 holders.
The top 10 institutions account for 56.9% of all reported 13F value in BLLN, and the top 25 account for 83.1%.
Across the largest Diagnostics & Lab Testing peers, institutional ownership levels are: QUCY (0.4%), NIKI (11.7%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.